UMVA has learned that a Haitian national in Florida was convicted in a staggering healthcare fraud conspiracy that siphoned more than $58 million from Medicare, Medicaid and private insurers through a federal drug discount program.
In 2025, prosecutors charged Jean Jethro Alexandre and his accomplices with orchestrating a web of fake patients and illicit kickbacks, all centered on fraudulent prescriptions for HIV and AIDS medication written by complicit nurse practitioners.
Alexandre cashed in on the scheme by filing insurance claims for prescriptions that never existed, then pocketed the difference between the discounted drug cost and the reimbursement paid by insurers.
The proceeds financed a life of excess: a fleet of luxury cars, a sprawling Miami‑area mansion, and a portfolio of investment properties that glittered with the spoils of deception.
This case has thrust the 340B Drug Pricing Program back into the spotlight, a federal initiative originally designed to help safety‑net providers serve low‑income patients but now criticized for weak oversight and rampant abuse.
Lawmakers argue that the program’s vast discounts, opaque contracts, and minimal transparency create a perfect storm for fraudsters to strike, as Alexandre’s scheme demonstrates.
By secretly owning a nonprofit health clinic, Alexandre bought drugs at steep discounts, had them dispensed through pharmacies, and then collected reimbursements from Medicare and Medicaid—only to find the prescriptions were fabricated or the drugs destroyed.
While legitimate providers can use the program to generate revenue, the Government Accountability Office has warned that the underlying prescriptions in Alexandre’s case were illegal, turning a legitimate mechanism into a tool of theft.
Congressional leaders have called for tighter scrutiny, with representatives emphasizing that the program must return to its original intent of aiding vulnerable patients, not enriching criminals.
In addition to a nearly decade‑long prison sentence, Alexandre faces roughly $14.3 million in restitution and will be barred from reentering the United States without special permission.
The federal government has intensified its crackdown on fraud across Medicaid, Medicare, and other programs, signaling a broader commitment to eradicating waste and abuse.
As the investigation unfolds, the story serves as a stark reminder that unchecked loopholes in well‑meaning programs can be weaponized by audacious schemers seeking personal gain at the expense of taxpayers and patients alike.
